Skip to content
OpenCapital
Get started

Wingstop WING Non Cash Investment Income

Non Cash Investment Income at other companies

Ionis Pharmaceuticals logo
Ionis PharmaceuticalsIONS
$25.48M+3.3%
Blue Owl Technology Finance Corp. logo
Blue Owl Technology Finance Corp.OTF
$172.59M+71.4%
Axis Capital Holders logo
Axis Capital HoldersAXS
-$27.36M+8.8%
Choice Hotels International logo
Choice Hotels InternationalCHH
$1.8M+18.8%
Axis Capital Holders logo
Axis Capital HoldersAXS
$184.74M-11.1%
Main Street Capital logo
Main Street CapitalMAIN
$87.84M-2.2%

Other financials

Income statement

See full
Revenue$183.7M+7.4%
Gross profit$159.0M+7.3%
Operating income$50.4M+31.7%
Net income$29.9M-67.6%
EPS (diluted)$1.08-66.7%

Balance sheet

See full
Cash & equivalents$128.8M-48.8%
Total debt$1.3B+0.2%
Total equity-$799.2M-11.8%
Total assets$648.9M-6.9%

Cash flow

See full
Operating cash flow$61.4M+143%
CapEx$17.7M+121%
Free cash flow$43.7M+153%

Valuation

See full
Market cap$4.41B-34.1%

Profitability

See full
Gross margin86.2%+0.5pp
Operating margin27%+2.2pp
Net margin15.8%-10.7pp
FCF margin19.7%+4.6pp

Returns & leverage

See full
Current ratio2.2×-1.3×

Where this comes from

Reported directly by Wingstop in its filing.

Tagged under the XBRL concept wing:NonCashInvestmentIncome.

The official record: Wingstop’s 10-Q, filed April 29, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wingstop's non cash investment income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Wingstop's non cash investment income?
Wingstop (WING) reported non cash investment income of $2.41M in Q1 2026.
How has Wingstop's non cash investment income changed year-over-year?
Wingstop's non cash investment income increased by 64.0% year-over-year, from $1.47M to $2.41M.
What does non cash investment income mean?
This metric represents income recognized from investment activities that does not involve an immediate cash inflow. It typically reflects adjustments for non-cash gains or losses on financial instruments or equity-method investments. Monitoring this helps investors distinguish between reported earnings and actual cash-generating capacity from the company's investment portfolio.